Partnervest Advisory Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$244K Buy
+2,810
New +$243K 0.08% 203
2019
Q3
– Sell
-2,200
Closed -$201K – 277
2019
Q2
$201K Buy
+2,200
New +$186K 0.08% 208
2014
Q3
– Sell
-1,812
Closed -$147K – 587
2014
Q2
$147K Sell
1,812
-19
-1% -$1.49K 0.07% 191
2014
Q1
$140K Sell
1,831
-112
-6% -$8.16K 0.06% 190
2013
Q4
$140K Hold
1,943
– – 0.07% 181
2013
Q3
$134K Sell
1,943
-712
-27% -$47.1K 0.07% 163
2013
Q2
$168K Buy
+2,655
New +$173K 0.08% 111

Other funds holding NVS

Partnervest Advisory Services's NVS Position: Q3 2020 in Review

Partnervest Advisory Services opened a new position in Novartis (NVS) in Q3 2020: 2,810 shares worth $244K. The stake represents 0.08% of the portfolio and ranks #203 among its holdings. This is a return to the name: Partnervest Advisory Services previously reported a position in NVS as recently as Q2 2019.

Partnervest Advisory Services first reported a position in NVS in Q2 2013 and has held it in 7 quarters since. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • Partnervest Advisory Services held 2,810 shares of Novartis worth $244K as of Q3 2020.
  • Novartis was a new Partnervest Advisory Services position in Q3 2020.
  • Novartis made up 0.08% of Partnervest Advisory Services's portfolio in Q3 2020, its #203 holding.
  • Partnervest Advisory Services first reported a position in Novartis in Q2 2013 and has held it in 7 quarters since.
  • 1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Partnervest Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.